Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Other financing activities (2021 - 2023)

Journey Medical filings provide 3 years of Other financing activities readings, the most recent being $380000.0 for Q4 2023.

  • On a quarterly basis, Other financing activities changed N/A to $380000.0 in Q4 2023 year-over-year; TTM through Dec 2025 was $380000.0, a N/A change, with the full-year FY2025 number at $75000.0, up 50.0% from a year prior.
  • Other financing activities hit $380000.0 in Q4 2023 for Journey Medical, up from -$157000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $1.4 million in Q1 2021 to a low of -$157000.0 in Q3 2022.
  • Median Other financing activities over the past 3 years was $214000.0 (2022), compared with a mean of $370000.0.
  • The widest YoY moves for Other financing activities: up 12.29% in 2022, down 133.84% in 2022.
  • Journey Medical's Other financing activities stood at $464000.0 in 2021, then plummeted by 133.84% to -$157000.0 in 2022, then skyrocketed by 342.04% to $380000.0 in 2023.
  • The last three reported values for Other financing activities were $380000.0 (Q4 2023), -$157000.0 (Q3 2022), and $157000.0 (Q2 2022) per Business Quant data.